Hubei Sishui Liunian E-commerce Co., Ltd. – Trademark Portfolio

Entity Type: 99

Hubei Sishui Liunian E-commerce Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SIVLNIAN. The owner is based in Hubei Province.

Caohe Town, Qichun County,Huanggang City

No. 60,Lane 2,Xincun Rd,Xiacao Community

Hubei Province 435399 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SIVLNIAN
SIVLNIAN
Registered 2024

Trademark Classifications

Hubei Sishui Liunian E-commerce Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Hubei Sishui Liunian E-commerce Co., Ltd. have?

Hubei Sishui Liunian E-commerce Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Hubei Sishui Liunian E-commerce Co., Ltd. file in?

Hubei Sishui Liunian E-commerce Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Hubei Sishui Liunian E-commerce Co., Ltd.'s most well-known trademarks?

Hubei Sishui Liunian E-commerce Co., Ltd.'s registered trademark portfolio includes well-known marks such as SIVLNIAN. These are among 1 currently registered trademark in the portfolio.

What is Hubei Sishui Liunian E-commerce Co., Ltd.'s trademark registration success rate?

Hubei Sishui Liunian E-commerce Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.